secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2024-09-27T23:59:59+00:00
Accession:  0001493152-24-038544
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals sells 250 Series B Preferred shares for $250,000 in fourth closing under SPA
--------------------------------------------------------------------------------

- Sold 250 Series B Preferred shares to institutional accredited investor for $250,000; effective price at 10% discount to $1,100 stated value.
- Total 750 of 1,000 possible Series B shares sold to date; 250 remain available for future sale.
- Full conversion at $0.15 floor price yields 1,833,333 common shares; shareholder approval obtained for >19.99% issuance.
- Issuance exempt from registration under Section 4(a)(2) and Rule 506 of Regulation D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315224038544/0001493152-24-038544-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315224038544/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-038544

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer